HUTCHMED (China) Ltd Files Routine 6-K

Ticker: HMDCF · Form: 6-K · Filed: May 17, 2024 · CIK: 1648257

Sentiment: neutral

Topics: sec-filing, disclosure, foreign-private-issuer

TL;DR

HUTCHMED filed a 6-K, standard disclosure, no major news.

AI Summary

HUTCHMED (China) Limited filed a Form 6-K on May 17, 2024, reporting its status as a foreign private issuer. The filing does not contain specific financial figures or operational updates but serves as a routine disclosure.

Why It Matters

This filing indicates HUTCHMED is meeting its ongoing disclosure obligations as a foreign private issuer with the SEC, which is important for maintaining its listing and investor confidence.

Risk Assessment

Risk Level: low — This is a routine administrative filing with no new material information that would typically impact stock price.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange, or that it has distributed or is required to distribute to its security holders.

What specific information is included in this particular 6-K filing?

This specific 6-K filing primarily serves as a cover document and an exhibit index, indicating that HUTCHMED (China) Limited is fulfilling its reporting obligations. It does not contain detailed financial results or operational updates within the provided text.

When was this Form 6-K filed with the SEC?

This Form 6-K was filed with the SEC on May 17, 2024.

What is HUTCHMED's principal executive office address?

HUTCHMED's principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.

Does HUTCHMED file its annual reports on Form 20-F or 40-F?

HUTCHMED indicates that it files its annual reports under cover of Form 20-F.

Filing Stats: 197 words · 1 min read · ~1 pages · Grade level 14 · Accepted 2024-05-17 10:02:55

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to the highlights of sovleplenib phase III ESLIM-01 study and hematological malignancy programs data to be presented at the upcoming EHA2024 Congress Exhibit 99.2 Announcement relating to the retirement of Chairman, appointment of new Chairman and change of members of board committees 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: May 17, 2024 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing